Ayala is headquartered in Wilmington, Delaware.
Ayala disclosed revenue of 4M USD for 2021 and 4M USD for 2020.
Ayala has 20 employees.
Ayala is a life science company.
1007 North Orange Street 4th Floor,
Wilmington, Delaware
19802
United States,
+857 444 0553
www.ayalapharma.com
Ayala is a clinical-stage oncology company formed after acquiring an exclusive, worldwide license to its product candidates AL101 and AL102 from Bristol-Myers Squibb (BMS). It is focused on developing and commercializing small molecule therapeutics for patients living with rare and aggressive cancers, especially in genetically defined patient populations. Ayala is based in Wilmington, Delaware.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | 1 | - | - | - | 1 |
| Sell (0.2/yr) | # | - | - | - | - | 1 | - | 1 |
| 2 | ||||||||
| Financial | Deals |
|---|---|
|
AGP/Alliance Global Partners |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
